GUANZE MEDICAL(02427.HK)

Company Encyclopedia
View More
name
GUANZE MEDICAL
02427.HK
Guanze Medical Information Industry (Holding) Co., Ltd., an investment holding company, provides medical imaging solutions in the People’s Republic of China. The company sells medical imaging film products for hospitals and healthcare institutions. It also offers medical imaging cloud services; and software solutions. The company was founded in 2015 and is headquartered in Jinan, the People’s Republic of China.
165.99 B
02427.HKMarket value -Rank by Market Cap -/-

Financial Score

01/01/2026 Update
B
Health Care DistributorsIndustry
Industry Ranking2/21
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE8.22%B
    • Profit Margin14.05%B
    • Gross Margin42.01%B
  • Growth ScoreA
    • Revenue YoY21.45%A
    • Net Profit YoY81.20%A
    • Total Assets YoY12.29%B
    • Net Assets YoY11.29%B
  • Cash ScoreB
    • Cash Flow Margin711.77%B
    • OCF YoY21.45%A
  • Operating ScoreC
    • Turnover0.51C
  • Debt ScoreA
    • Gearing Ratio13.28%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Guanze Medical Appoints Cheng Cheung King as Company Secretary and Authorised Representative

    Guanze Intelligent Medical Information Industry Holding Co. Ltd. announced that Zhang Senquan will step down as company secretary and authorised representative effective 31 December 2025. Cheng Cheung King has been appointed to both positions, also effective from 31 December 2025.

    Reuters·
    HK
    02427
    +3.92%
    Reuters·
    HK
    02427
    +3.92%

    Hong Kong Stock Movement: GUANZE MEDICAL surged 25.86%

    GUANZE MEDICAL surged 25.86%; Yaoshi Bang rose 6.63%, with a transaction volume reaching HKD 260 million; China National Pharmaceutical Group increased by 0.05%, with a transaction volume of HKD 6.26 million; Health 160 rose 1.46%, with a transaction volume of HKD 2.31 million; Shanghai Pharmaceuticals increased by 0.08%, with a market value of HKD 45 billion

    HK Stock Movers Tracker·
    HK
    02427
    +3.92%
    HK Stock Movers Tracker·
    HK
    02427
    +3.92%

    Guanze Medical Information Industry (Holding) (HKG:2427) May Have Issues Allocating Its Capital

    Guanze Medical Information Industry (Holding) (HKG:2427) has shown a declining trend in Return on Capital Employed (ROCE), falling from 39% over the past five years to 7.7%. Despite this, the company is experiencing revenue growth and reinvesting in operations, which may benefit shareholders in the long run. The stock has returned 48% to shareholders over the last year, indicating potential worth for further investigation. However, investors should be aware of three warning signs before considering an investment.

    Simplywall·
    HK
    02427
    +3.92%
    Simplywall·
    HK
    02427
    +3.92%

    Guanze Medical Information Moves Hong Kong Office to Infinitus Plaza

    Guanze Medical Information Industry (Holding) Co., Ltd. has announced a relocation of its Hong Kong office to Infinitus Plaza, effective September 1, 2025. The new address will be 2908, Level 29, Infinitus Plaza, 199 Des Voeux Road Central, Sheung Wan, Hong Kong. All contact details will remain unchanged. This announcement was generated by Public Technologies and is for informational purposes only.

    Reuters·
    HK
    02427
    +3.92%
    Reuters·
    HK
    02427
    +3.92%

    GUANZE MEDICAL released its interim results, with a profit attributable to shareholders of HKD 3.368 million, turning a profit compared to the same period last year

    According to the Zhitong Finance APP, GUANZE MEDICAL announced its performance for the six months ending June 30, 2025. The group achieved revenue of RMB 31.855 million during the period, a year-on-year decrease of 20.42%; the profit attributable to the company's owners was RMB 3.368 million, turning from a loss to a profit year-on-year; basic earnings per share were RMB 0.003

    Zhitong·
    HK
    02427
    +3.92%
    Zhitong·
    HK
    02427
    +3.92%
    © 2026 Longbridge｜Disclaimer